EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Coronary Sinus Reducer: History, Current Applications, and Future Perspectives

Fabrizio Ugo, Marco Franzino iD, Chiara Cavallino, Mohamed Abdirashid, Ludovica Maltese, Francesco Rametta

Reviews in Cardiovascular Medicine · 27.11.2025 · 26 (11)

DOI: 10.31083/rcm39309 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 27.11.2025. Verfasst von Fabrizio Ugo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Sant'Andrea Hospital, 13100 Vercelli, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronary sinus reducer (CSR) is a percutaneous device designed to improve coronary blood flow and alleviate symptoms of refractory angina in patients with severe coronary artery disease (CAD) who are unsuitable for revascularization therapy. CSR originated from earlier surgical techniques, such as coronary sinus ligation (CSL), and functions by narrowing the coronary sinus to enhance perfusion in ischemic myocardial territories—particularly in the subendocardial regions—while also reducing microvascular resistance and increasing capillary recruitment. CSR is currently recognized as an effective treatment for patients with chronic refractory angina, especially those deemed ineligible for revascularization according to current European Society of Cardiology (ESC) guidelines. Moreover, emerging studies are expanding the understanding of the mechanism of action involved in CSR, demonstrating that this technique may also improve microvascular function, particularly in patients with coronary microvascular dysfunction. These trials have shown significant improvements in coronary microcirculation and reductions in angina symptoms, suggesting that CSR may have therapeutic potential beyond obstructive CAD. Thus, CSR may represent a promising treatment option for microvascular ischemia, thereby broadening its clinical applicability to patients with angina/ischemia and non-obstructive coronary arteries (ANOCA/INOCA).

Schlagwörter

Stichwörter der Autor:innen

coronary artery diseasecoronary sinus reducerrefractory angina

Autor:innen und Institutionen

  • Cardiology Department, Sant'Andrea Hospital, 13100 Vercelli, Italy.

ORCID-Profile: Marco Franzino

Zitieren

APA

Ugo, F., Franzino, M., Cavallino, C., Abdirashid, M., Maltese, L., & Rametta, F. (2025). Coronary Sinus Reducer: History, Current Applications, and Future Perspectives. Reviews in Cardiovascular Medicine, 26(11). https://doi.org/10.31083/rcm39309

Vancouver

Ugo F, Franzino M, Cavallino C, Abdirashid M, Maltese L, Rametta F. Coronary Sinus Reducer: History, Current Applications, and Future Perspectives. Reviews in Cardiovascular Medicine. 2025;26(11). doi:10.31083/rcm39309

BibTeX
@article{Ugo2025,
  author = {Ugo, Fabrizio and Franzino, Marco and Cavallino, Chiara and Abdirashid, Mohamed and Maltese, Ludovica and Rametta, Francesco},
  title = {Coronary Sinus Reducer: History, Current Applications, and Future Perspectives},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2025},
  volume = {26},
  number = {11},
  doi = {10.31083/rcm39309}
}
Kostenlos starten →